Dr. Vince Featured Articles

  1. 3 Essential Components Of Successful Renal And Hepatic Impairment Studies 9/10/2026

    Kidney and liver function affect how drugs work in the body. Learn how impairment studies help set safe, effective dosing for these patients.

  2. Strategic Implications Of The Single Phase 3 Approval Paradigm 7/21/2026

    As FDA single-trial approvals gain traction, CNS developers need stronger early evidence. Learn how biomarkers, patient selection, and regulatory strategy can accelerate development.

  3. Understanding Subjective Outcome Measures In HAP Studies 4/28/2026

    Understanding how a participant "feels" is essential for drug safety. Explore how subjective measures and specialized training provide the data needed to evaluate human abuse potential.

  4. Statistical Analysis In Human Abuse Potential Studies 4/28/2026

    Gain clarity on the rigorous statistical frameworks and Emax endpoint analyses required to evaluate drug abuse potential and satisfy complex regulatory safety standards.